Browse News
Filter News
Found 281 articles
-
Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update
3/6/2024
Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced fourth quarter 2023 financial results and provided a corporate update.
-
RRD International is now RRD Biopharma Development
2/28/2024
RRD International has announced today that it launched its new brand RRD Biopharma Development reflecting its unique offering of delivering strategy-driven product development services to biopharmaceutical companies and investors.
-
DirectMed Imaging Unifies With Technical Prospects to Become One Company and One Brand
2/5/2024
DirectMed Imaging announces Technical Prospects, the company it acquired in August of 2023, will now fully join forces under the DirectMed Imaging name.
-
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
1/29/2024
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”) today unveiled its new corporate branding to officially begin doing business as Lifeward™ (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability.
-
Shifox Re-Brands as Alopex and Announces Completion of Investment Round
1/25/2024
Shifox, the provider of complex care management services and technology, has rebranded under the name Alopex powered by Shifox.
-
AcelRx Announces Rebranding With Name Change to Talphera, Inc.
1/9/2024
AcelRx Pharmaceuticals, Inc. today announced the rebranding of the Company, with a name change to Talphera, Inc. ("Talphera").
-
Under an agreement with Johnson & Johnson’s Actelion Pharmaceuticals, the rights to the multiple sclerosis drug Ponvory in the U.S. and Canada will be transferred to Vanda Pharmaceuticals.
-
TrialSpark Rebrands as Formation Bio, Continuing Its Commitment to Advancing Drug Development Innovation
12/6/2023
TrialSpark, a tech-driven drug developer with its own portfolio of clinical stage drug assets, is rebranding to Formation Bio.
-
Goldcup 34064 AB Announces Vironova BioAnalytics Acquired by Investor Group
11/20/2023
Vironova BioAnalytics, a leading provider of transmission electron microscopy services, is pleased to announce its acquisition led by QuatreLab with the participation of Accord Investment Partners and Venture Targeter AB.
-
PsychoGenics Launches an Updated Corporate Identity and Brand
11/10/2023
PsychoGenics Inc., the leading contract research organization specializing in central nervous system focused preclinical and translational drug discovery services, is proud to unveil its refreshed corporate identity and brand.
-
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
10/11/2023
Renovaro Biosciences Inc., a biotechnology corporation focusing on cell, gene, and immunotherapy, has announced that Avram Miller will join its Board of Directors.
-
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
10/10/2023
Renovaro Biosciences Inc. is pleased to announce the appointment of Leni Boeren and Ruud Hendriks as Independent Directors.
-
Spineology® Unveils Visionary Rebrand: Pioneering the Tools of Tomorrow
10/5/2023
Spineology Inc., the leader in ultra-minimally invasive spine surgery, is proud to announce a transformative rebranding initiative that positions the company at the forefront of innovation in spine care.
-
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
9/29/2023
Renovaro Biosciences Inc., an advanced, preclinical biotechnology firm in cell, gene and immunotherapy has signed a definitive agreement to combine with GEDi Cube Intl Ltd., an AI medical technology company, in which GEDi Cube will become a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
-
Hybrigenics Re-brands to 'ATON' as Company Signals New Global Vision and Strategy to Advance Breakthrough Treatments
9/26/2023
Hybrigenics, a leading French publicly listed bioscience firm, has today announced its re-brand to 'ATON' as it signifies the culmination of a transformative shift in its vision and strategy that began two years ago.
-
The companies have announced the impending closures of their respective businesses. Histogen will lay off most of its employees by the end of September. Fresh Tracks will do so by early October.
-
Sterling Medical Devices and RBC Medical Innovations Rebrand as Vantage MedTech
9/12/2023
Sterling Medical Devices and RBC Medical Innovations announced the rebranding of the combined company as Vantage MedTech.
-
Angus Completes Corporate Rebrand, Changes Name to Advancion
9/1/2023
ANGUS Chemical Company announced the completion of its corporate rebrand and corporate name change to Advancion Corporation, effective September 1, 2023.
-
Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
8/10/2023
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results for the third quarter of fiscal 2023 ended June 30, 2023.
-
GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET®
7/11/2023
GI Dynamics, creator of the world's first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic Medical and the introduction of RESET, formally known as EndoBarrier®.